Get the Stockscreener App
93.86
2.69%
-2.59
Illumina Inc stock is traded at $93.86, with a volume of 1.57M.
It is down -2.69% in the last 24 hours and down -1.71% over the past month.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
See More
Previous Close:
$96.45
Open:
$96.49
24h Volume:
1.57M
Relative Volume:
0.91
Market Cap:
$14.43B
Revenue:
$4.28B
Net Income/Loss:
$1.26B
P/E Ratio:
11.88
EPS:
7.9
Net Cash Flow:
$943.00M
1W Performance:
-8.09%
1M Performance:
-1.71%
6M Performance:
+31.71%
1Y Performance:
-34.71%
1-Day Range:
$91.65
$96.49
1-Week Range:
$91.65
$102.68
52-Week Range:
$68.70
$156.66
Illumina Inc Stock (ILMN) Company Profile
Name
Illumina Inc
Sector
Industry
Phone
(858) 202-4500
Address
5200 ILLUMINA WAY, SAN DIEGO, CA
Compare ILMN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ILMN
Illumina Inc
|
93.86 | 14.82B | 4.28B | 1.26B | 943.00M | 7.90 |
|
TMO
Thermo Fisher Scientific Inc
|
524.80 | 201.90B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
202.46 | 146.42B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
616.15 | 50.30B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
136.62 | 39.72B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
198.17 | 34.51B | 15.70B | 1.24B | 2.01B | 6.9036 |
Illumina Inc Stock (ILMN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-12-25 | Downgrade | Daiwa Securities | Outperform → Neutral |
| Jul-11-25 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
| Mar-04-25 | Reiterated | Citigroup | Neutral |
| Feb-28-25 | Downgrade | HSBC Securities | Buy → Hold |
| Feb-10-25 | Downgrade | Barclays | Equal Weight → Underweight |
| Feb-07-25 | Downgrade | TD Cowen | Buy → Hold |
| Dec-11-24 | Downgrade | Citigroup | Buy → Neutral |
| Nov-12-24 | Resumed | Morgan Stanley | Equal-Weight |
| Oct-17-24 | Upgrade | HSBC Securities | Hold → Buy |
| Aug-28-24 | Upgrade | Argus | Hold → Buy |
| Aug-16-24 | Upgrade | Daiwa Securities | Neutral → Buy |
| Aug-14-24 | Upgrade | Barclays | Underweight → Equal Weight |
| Aug-14-24 | Upgrade | TD Cowen | Hold → Buy |
| Jul-10-24 | Upgrade | Citigroup | Neutral → Buy |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Jan-16-24 | Downgrade | HSBC Securities | Buy → Hold |
| Jan-04-24 | Downgrade | TD Cowen | Outperform → Market Perform |
| Dec-18-23 | Upgrade | Scotiabank | Sector Perform → Sector Outperform |
| Dec-15-23 | Upgrade | Bernstein | Underperform → Mkt Perform |
| Dec-14-23 | Initiated | Guggenheim | Buy |
| Dec-14-23 | Initiated | Stephens | Overweight |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Dec-12-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Dec-11-23 | Upgrade | Citigroup | Sell → Neutral |
| Nov-10-23 | Downgrade | Canaccord Genuity | Buy → Hold |
| Sep-28-23 | Initiated | Bernstein | Underperform |
| Jul-05-23 | Resumed | JP Morgan | Neutral |
| Jan-25-23 | Downgrade | Argus | Buy → Hold |
| Jan-05-23 | Initiated | Scotiabank | Sector Perform |
| Dec-12-22 | Downgrade | Citigroup | Neutral → Sell |
| Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
| Oct-04-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Sep-28-22 | Upgrade | Evercore ISI | In-line → Outperform |
| Aug-25-22 | Initiated | Credit Suisse | Neutral |
| Jul-13-22 | Downgrade | Barclays | Equal Weight → Underweight |
| Jan-18-22 | Upgrade | Stifel | Hold → Buy |
| Jan-11-22 | Upgrade | Barclays | Underweight → Equal Weight |
| Jan-07-22 | Upgrade | BofA Securities | Underperform → Neutral |
| Jan-06-22 | Resumed | Morgan Stanley | Equal-Weight |
| Jan-06-22 | Resumed | Piper Sandler | Overweight |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Aug-19-21 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Jun-01-21 | Upgrade | Evercore ISI | Underperform → In-line |
| Mar-31-21 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Mar-31-21 | Upgrade | Canaccord Genuity | Hold → Buy |
| Mar-03-21 | Initiated | Barclays | Underweight |
| Dec-22-20 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-17-20 | Upgrade | BTIG Research | Neutral → Buy |
| Oct-13-20 | Downgrade | Guggenheim | Buy → Neutral |
| Sep-30-20 | Initiated | Atlantic Equities | Overweight |
| Sep-29-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Sep-22-20 | Downgrade | Stifel | Buy → Hold |
| Sep-22-20 | Downgrade | UBS | Buy → Neutral |
| Sep-21-20 | Upgrade | Guggenheim | Neutral → Buy |
| Sep-21-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-09-20 | Initiated | Morgan Stanley | Equal-Weight |
| Aug-07-20 | Downgrade | Evercore ISI | In-line → Underperform |
| Aug-07-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-07-20 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-24-20 | Downgrade | Citigroup | Buy → Neutral |
| Apr-21-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-08-20 | Initiated | Wells Fargo | Underweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Jan-02-20 | Downgrade | Evercore ISI | Outperform → In-line |
| Nov-15-19 | Initiated | Stifel | Buy |
| Oct-25-19 | Initiated | Guggenheim | Buy |
View All
Illumina Inc Stock (ILMN) Latest News
10x Genomics, BioMarin Pharmaceutical, AMN Healthcare Services, Illumina, and Moderna Stocks Trade Down, What You Need To Know - TradingView
Precision Medicine Market Size Booms at 16.35% CAGR, Expected to Reach USD 463.11 Billion by 2034 - GlobeNewswire Inc.
Sentiment analysis tools applied to Illumina Inc.Market Activity Summary & Free High Return Stock Watch Alerts - newser.com
Can volume confirm reversal in Illumina Inc.2025 Short Interest & Comprehensive Market Scan Insights - newser.com
3,608 Shares in Illumina, Inc. $ILMN Bought by Allegiance Financial Group Advisory Services LLC - MarketBeat
Illumina Inc. stock momentum explainedOptions Play & Real-Time Volume Spike Alerts - newser.com
QRG Capital Management Inc. Has $711,000 Stock Holdings in Illumina, Inc. $ILMN - MarketBeat
Why Illumina (ILMN) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Illumina Inc. stock trendline breakdown2025 Buyback Activity & Expert Approved Trade Ideas - newser.com
Illumina Inc. stock volume spike explainedWeekly Market Report & Reliable Price Breakout Alerts - newser.com
What data driven models say about Illumina Inc.’s future2025 Earnings Surprises & Real-Time Volume Trigger Notifications - newser.com
Illumina (NASDAQ:ILMN) Earns Sell (D+) Rating from Weiss Ratings - MarketBeat
Illumina, Inc. (ILMN): A Bull Case Theory - MSN
Is Illumina Inc. (ILU) stock positioned for secular growthIPO Watch & Community Verified Trade Signals - newser.com
Wealthcare Advisory Partners LLC Has $851,000 Position in Illumina, Inc. $ILMN - MarketBeat
Illumina’s SWOT analysis: genetic sequencing giant faces headwinds By Investing.com - Investing.com Australia
Celebrating milestones and the future of oncology in China - Illumina
Mirae Asset Global Investments Co. Ltd. Reduces Stake in Illumina, Inc. $ILMN - MarketBeat
Will Illumina (ILMN) Beat Estimates Again in Its Next Earnings Report? - sharewise.com
Illumina, Inc. Experiences Evaluation Revision Amidst Ongoing Market Challenges - Markets Mojo
Illumina (ILMN) Analyst Rating Update: Evercore ISI Lowers Price Target | ILMN Stock News - GuruFocus
Illumina (NASDAQ:ILMN) Price Target Lowered to $132.00 at Evercore ISI - MarketBeat
Ultima Genomics UG 100 platform vs. Illumina NovaSeq X Series whole-genome sequencing benchmarking - Illumina
Assessing Illumina’s Value After 6% Weekly Rally and New Cost-Cutting Initiative - Yahoo
Slow Capital Inc. Sells 23,118 Shares of Illumina, Inc. $ILMN - MarketBeat
Illumina, Inc. Experiences Revision in Its Stock Evaluation Amid Competitive Market Dynamics - Markets Mojo
Illumina Stock Forms Golden Cross, Signaling Potential Bullish Breakout - Markets Mojo
How to interpret RSI for Illumina Inc. stock2025 Big Picture & Real-Time Chart Breakout Alerts - newser.com
Will Illumina’s (ILMN) AI-Powered BioInsight Reshape Its Precision Medicine Strategy? - Yahoo Finance
United States RNA Sequencing Market Set to Revolutionize - openPR.com
Will Illumina Inc. (ILU) stock test record highs in 2025Buy Signal & Verified Swing Trading Watchlists - newser.com
Will Illumina Inc. stock benefit from commodity pricesTrade Signal Summary & Low Risk Entry Point Guides - newser.com
Is Illumina Inc. still worth holding after the dipQuarterly Growth Report & Technical Pattern Recognition Alerts - newser.com
Backtesting results for Illumina Inc. trading strategiesJuly 2025 Recap & High Accuracy Buy Signal Tips - newser.com
Will Illumina Inc. stock continue dividend increasesJuly 2025 Closing Moves & Momentum Based Trading Signals - newser.com
A Look at Illumina’s (ILMN) Valuation Following Analyst Skepticism on BioInsight and New Partnerships - Sahm
Legacy Trust Trims Stake in Illumina, Inc. $ILMN - MarketBeat
Can Illumina Inc. stock resist sector downturnsTrade Analysis Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Robeco Institutional Asset Management B.V. Sells 354,433 Shares of Illumina, Inc. $ILMN - MarketBeat
Why Illumina Inc. stock is in analyst buy zoneJuly 2025 Closing Moves & Weekly Top Gainers Alerts - newser.com
4,321 Shares in Illumina, Inc. $ILMN Acquired by Greenwood Capital Associates LLC - MarketBeat
4,544 Shares in Illumina, Inc. $ILMN Purchased by Pure Financial Advisors LLC - MarketBeat
State of Alaska Department of Revenue Lowers Holdings in Illumina, Inc. $ILMN - Defense World
Illumina (ILMN) Is Up 7.7% After Launching AI-Focused BioInsight Unit for Drug Discovery Innovation - simplywall.st
ILMN Stock Set to Benefit From the Launch of New BioInsight Division - Yahoo Finance
Why Illumina Inc. stock could see breakout soonWatch List & Real-Time Volume Trigger Notifications - newser.com
Hardman Johnston Global Advisors LLC Raises Holdings in Illumina, Inc. $ILMN - MarketBeat
Greenleaf Trust Has $758,000 Stock Position in Illumina, Inc. $ILMN - MarketBeat
What consensus target says about Illumina Inc. (ILU) stock2025 Stock Rankings & Consistent Profit Alerts - newser.com
Genomics, Illumina team up to capture Asia-Pacific whole genome sequencing market - digitimes
Illumina (ILMN) Stock Falls on Barclays Underweight RatingNews and Statistics - IndexBox
Illumina Inc Stock (ILMN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Illumina Inc Stock (ILMN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Thaysen Jacob | Chief Executive Officer |
May 12 '25 |
Buy |
80.88 |
6,500 |
525,732 |
77,540 |
| Thaysen Jacob | Chief Executive Officer |
May 13 '25 |
Buy |
80.84 |
5,850 |
472,942 |
83,390 |
0.17%
2.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):